{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:47:11Z","timestamp":1777873631795,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204923"],"award-info":[{"award-number":["82204923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpba.2026.117404","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:55:56Z","timestamp":1770479756000},"page":"117404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring potential mechanism of Chuanzhi Qingyu recipe for vulnerable atherosclerosis plaques based on UPLC-Q-TOF-MSE, systems biology strategy, and experimental validation"],"prefix":"10.1016","volume":"274","author":[{"given":"Jiajun","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Huan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.jpba.2026.117404_bib1","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehaf314","article-title":"Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement","volume":"46","author":"Romeo","year":"2025","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.jpba.2026.117404_bib2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/eurjpc\/zwad389","article-title":"Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database","volume":"31","author":"Bentzel","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"16","key":"10.1016\/j.jpba.2026.117404_bib3","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/eurjpc\/zwae194","article-title":"Two-year prognosis and cardiovascular disease prevention after acute coronary syndrome: the role of cardiac rehabilitation-a French nationwide study","volume":"31","author":"Blacher","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.jpba.2026.117404_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.140113","article-title":"Component analysis using UPLC-Q-TOF\/MS and quality evaluation using fingerprinting and chemometrics for hops","volume":"457","author":"Gao","year":"2024","journal-title":"Food Chem."},{"issue":"11","key":"10.1016\/j.jpba.2026.117404_bib5","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.apsb.2022.08.022","article-title":"New opportunities and challenges of natural products research: when target identification meets single-cell multiomics","volume":"12","author":"Zhu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpba.2026.117404_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114734","article-title":"Prediction model for different progressions of Atherosclerosis in ApoE(-\/-) mice based on lipidomics","volume":"214","author":"Wang","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117404_bib7","series-title":"Experimental Methodology of Pharmacological","author":"Wei","year":"2011"},{"issue":"17","key":"10.1016\/j.jpba.2026.117404_bib8","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.7150\/thno.117243","article-title":"Autophagy-driven lipid regulation by an herbal decoction alleviates cardiac lipotoxicity in severe acute pancreatitis","volume":"15","author":"Yang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jpba.2026.117404_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156559","article-title":"JiGuCao capsule formula alleviates metabolic fatty liver disease by regulating the gut-liver axis and lipid metabolism","volume":"140","author":"Qi","year":"2025","journal-title":"Phytomedicine"},{"issue":"D1","key":"10.1016\/j.jpba.2026.117404_bib10","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.jpba.2026.117404_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jms.1777","article-title":"MassBank: a public repository for sharing mass spectral data for life sciences","volume":"45","author":"Horai","year":"2010","journal-title":"J. Mass Spectrom."},{"issue":"D1","key":"10.1016\/j.jpba.2026.117404_bib12","doi-asserted-by":"crossref","first-page":"D1110","DOI":"10.1093\/nar\/gkad926","article-title":"BATMAN-TCM 2.0: an enhanced integrative database for known and predicted interactions between traditional Chinese medicine ingredients and target proteins","volume":"52","author":"Kong","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.jpba.2026.117404_bib13","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pinero","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.jpba.2026.117404_bib14","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.3390\/ijms21113946","article-title":"Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability","volume":"21","author":"Olejarz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jpba.2026.117404_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/biom9040129","article-title":"Matrix metalloproteinase 9 as a predictor of coronary atherosclerotic plaque instability in stable coronary heart disease patients with elevated lipoprotein(a) levels","volume":"9","author":"Ezhov","year":"2019","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.jpba.2026.117404_bib16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.123.322737","article-title":"ADAMTS-7 modulates atherosclerotic plaque formation by degradation of TIMP-1","volume":"133","author":"Sharifi","year":"2023","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.jpba.2026.117404_bib17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/ATVBAHA.121.316091","article-title":"Monocyte-chemoattractant protein-1 levels in human atherosclerotic lesions associate with plaque vulnerability","volume":"41","author":"Georgakis","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.jpba.2026.117404_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0021-9150(00)00672-9","article-title":"Soluble adhesion molecules and unstable coronary artery disease","volume":"156","author":"Parker","year":"2001","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jpba.2026.117404_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.103.4.491","article-title":"Soluble P-selectin and the risk of future cardiovascular events","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jpba.2026.117404_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MOL.0000000000000959","article-title":"Distinct roles of size-defined HDL subpopulations in cardiovascular disease","volume":"36","author":"Davidson","year":"2024","journal-title":"Curr. Opin. Lipido"},{"key":"10.1016\/j.jpba.2026.117404_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101222","article-title":"HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation","volume":"24","author":"Zhang","year":"2019","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.jpba.2026.117404_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/cells14030153","article-title":"Inflammatory pathways in coronary artery disease: which ones to target for secondary prevention?","volume":"14","author":"Cheng","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jpba.2026.117404_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jare.2024.06.016","article-title":"Challenges and advances in the management of inflammation in atherosclerosis","volume":"71","author":"Xing","year":"2025","journal-title":"J. Adv. Res."},{"issue":"9","key":"10.1016\/j.jpba.2026.117404_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"29","key":"10.1016\/j.jpba.2026.117404_bib25","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehad373","article-title":"Smooth muscle alpha-actin missense variant promotes atherosclerosis through modulation of intracellular cholesterol in smooth muscle cells","volume":"44","author":"Kaw","year":"2023","journal-title":"Eur. Heart J."},{"issue":"20","key":"10.1016\/j.jpba.2026.117404_bib26","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehac641","article-title":"JCAD promotes arterial thrombosis through PI3K\/Akt modulation: a translational study","volume":"44","author":"Liberale","year":"2023","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.jpba.2026.117404_bib27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/eurheartj\/ehaa770","article-title":"Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease","volume":"42","author":"Akhmedov","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.jpba.2026.117404_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/pr.119.017897","article-title":"Brothers in Arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment","volume":"72","author":"Frambach","year":"2020","journal-title":"Pharm. Rev."},{"issue":"10","key":"10.1016\/j.jpba.2026.117404_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.123.065959","article-title":"Flipped C-terminal ends of APOA1 promote ABCA1-dependent cholesterol efflux by small HDLs","volume":"149","author":"He","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jpba.2026.117404_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.jpba.2026.117404_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cvr\/cvz046","article-title":"Focal TLR4 activation mediates disturbed flow-induced endothelial inflammation","volume":"116","author":"Qu","year":"2020","journal-title":"Cardiovasc Res."},{"issue":"19","key":"10.1016\/j.jpba.2026.117404_bib32","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","article-title":"Targeting the CCL2-CCR2 axis for atheroprotection","volume":"43","author":"Georgakis","year":"2022","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.jpba.2026.117404_bib33","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/ATVBAHA.122.317492","article-title":"Pharmacological targeting of the CCL2\/CCR2 axis for atheroprotection: a meta-analysis of preclinical studies","volume":"42","author":"Zivkovic","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.jpba.2026.117404_bib34","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/cvr\/cvad091","article-title":"Thrombin-activated interleukin-1alpha drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production","volume":"119","author":"Burzynski","year":"2023","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.jpba.2026.117404_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1252384","article-title":"Membrane-bound Interleukin-1alpha mediates leukocyte adhesion during atherogenesis","volume":"14","author":"Maeder","year":"2023","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.jpba.2026.117404_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.121.053547","article-title":"Interleukin-1alpha Is a central regulator of leukocyte-endothelial adhesion in myocardial infarction and in chronic kidney disease","volume":"144","author":"Schunk","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jpba.2026.117404_bib37","article-title":"Protective effects of liraglutide on hypercholesterolemia-associated atherosclerosis involve attenuation of endothelial-monocyte adhesion through down-regulating the LOX-1\/NF-kappaB signaling pathway","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jpba.2026.117404_bib38","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.117.032636","article-title":"Cholesterol efflux pathways suppress inflammasome activation, NETosis, and atherogenesis","volume":"138","author":"Westerterp","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jpba.2026.117404_bib39","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/cells12101402","article-title":"PAI-1 Overexpression in valvular interstitial cells contributes to hypofibrinolysis in aortic stenosis","volume":"12","author":"Kopytek","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jpba.2026.117404_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tcb.2022.08.005","article-title":"Cut loose TIMP-1: an emerging cytokine in inflammation","volume":"33","author":"Schoeps","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.jpba.2026.117404_bib41","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/ijms23010340","article-title":"NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis","volume":"23","author":"Burger","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jpba.2026.117404_bib42","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/toxins15080512","article-title":"Quercetin alleviates lipopolysaccharide-induced cell oxidative stress and inflammatory responses via regulation of the TLR4-NF-kappaB signaling pathway in bovine rumen epithelial cells","volume":"15","author":"Jiang","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.jpba.2026.117404_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fphar.2017.00040","article-title":"Quercetin inhibits LPS-induced inflammation and ox-LDL-induced lipid deposition","volume":"8","author":"Xue","year":"2017","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.jpba.2026.117404_bib44","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10787-020-00714-6","article-title":"Baicalein exerts neuroprotective effect against ischaemic\/reperfusion injury via alteration of NF-kB and LOX and AMPK\/Nrf2 pathway","volume":"28","author":"Yuan","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jpba.2026.117404_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2025.110029","article-title":"Baicalein reduces cardiac inflammatory infiltration in EAM mice by blocking the CCL2-CCR2 signaling axis through its binding with TNF-alpha and CCR2","volume":"145","author":"Tong","year":"2025","journal-title":"J. Nutr. Biochem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:07:27Z","timestamp":1777572447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"alternative-id":["S0731708526000725"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117404","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring potential mechanism of Chuanzhi Qingyu recipe for vulnerable atherosclerosis plaques based on UPLC-Q-TOF-MSE, systems biology strategy, and experimental validation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117404"}}